ProtoKinetix, Inc. financial data

Symbol
PKTX on OTC
Industry
Pharmaceutical Preparations
Location
109 W. Main St., Dalton, OH
State of incorporation
NV
Fiscal year end
December 31
Former names
RJV NETWORK INC (to 5/24/2004)
Latest financial report
10-K - Q4 2024 - Mar 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 13.7 % -75.8%
Return On Equity -94.5 % +2.11%
Return On Assets -77.5 % +14%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 378M shares +8.9%
Common Stock, Shares, Outstanding 372M shares +7.41%
Entity Public Float 2.67M USD -61.1%
Common Stock, Value, Issued 1.99K USD +7.41%
Weighted Average Number of Shares Outstanding, Basic 359M shares +7.64%
Weighted Average Number of Shares Outstanding, Diluted 359M shares +7.64%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 99.6K USD -11.4%
General and Administrative Expense 61.5K USD -38.3%
Net Income (Loss) Attributable to Parent -364K USD +12.3%
Earnings Per Share, Basic 0 USD/shares -50%
Earnings Per Share, Diluted 0 USD/shares -50%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 6.74K USD -49.9%
Assets 466K USD -3%
Accounts Payable, Current 124K USD +178%
Liabilities, Current 124K USD +178%
Retained Earnings (Accumulated Deficit) -48.2M USD -0.76%
Stockholders' Equity Attributable to Parent 342K USD -21.5%
Liabilities and Equity 466K USD -3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -57.8K USD +31.8%
Net Cash Provided by (Used in) Financing Activities 50K USD -37.5%
Net Cash Provided by (Used in) Investing Activities -9.74K USD +29.2%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 372M shares +7.41%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.69K USD -54.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 6.53M USD +4.4%
Deferred Tax Assets, Gross 6.53M USD +4.4%
Additional Paid in Capital 48.6M USD +0.56%
Amortization of Intangible Assets 52.9K USD +9.56%
Deferred Tax Assets, Net of Valuation Allowance 0 USD